PhaseBio Pharmaceuticals Inc. (PHAS) NASDAQ
$0.07 - (-)
Market Cap: -
As of 11/02/22 12:00 AM EDT. Market closed.
PhaseBio Pharmaceuticals Inc. (PHAS)
NASDAQ
$0.07
- (-)
Market Cap: -
As of 11/02/22 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jonathan Mow
Full Time Employees
50
CEO Compensation (Base)
$358,971
CEO Compensation (Total)
$595,630
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jonathan Mow
Full Time Employees
50
CEO Compensation (Base)
$358,971
CEO Compensation (Total)
$595,630
URL
Address
1 Great Valley Pkwy Ste 30, Pennsylvania, Malvern, 19355-1423.
PRICE CHART FOR PHASEBIO PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.08
Previous Close
$0.07
Days Range
$0.07 - $0.09
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
49,858,116
Open
$0.08
Previous Close
$0.07
Days Range
$0.07 - $0.09
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
49,858,116
FINANCIAL STATEMENTS FOR PHASEBIO PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PHASEBIO PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Oct 25, 2022 | Sale | $0.15 | 1,784,109 | 262,264 | 4,857,525 | Oct 26, 2022, 04:41 PM |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Oct 25, 2022 | Sale | $0.15 | 1,784,109 | 262,264 | 4,857,525 | Oct 26, 2022, 04:41 PM |
| Arnold Susan Elizabeth | SVP, Technical Operations | May 20, 2022 | Option Exercise | $0.68 | 10,917 | 7,438 | 41,236 | May 24, 2022, 05:15 PM |
| Mow Jonathan P | Chief Executive Officer | May 20, 2022 | Option Exercise | $0.68 | 10,918 | 7,438 | 132,502 | May 24, 2022, 05:14 PM |
| Burkhardt Glen | SVP of Human Resources | May 20, 2022 | Option Exercise | $0.68 | 11,248 | 7,663 | 11,248 | May 24, 2022, 05:14 PM |
| Burkhardt Glen | SVP of Human Resources | May 23, 2022 | Sale | $0.79 | 11,248 | 8,886 | 0 | May 24, 2022, 05:14 PM |
| Hanson Kristopher | SVP and General Counsel | May 20, 2022 | Option Exercise | $0.68 | 4,831 | 3,291 | 8,463 | May 24, 2022, 05:13 PM |
| Birchall Jonathan | Chief Commercial Officer | May 20, 2022 | Option Exercise | $0.68 | 20,000 | 13,626 | 20,000 | May 24, 2022, 05:13 PM |
| Sharp John P | Chief Financial Officer | May 20, 2022 | Option Exercise | $0.68 | 6,026 | 4,106 | 65,767 | May 24, 2022, 05:12 PM |
| Hutson Nancy J | Director | Aug 18, 2021 | Buy | $3.08 | 3,000 | 9,240 | 4,000 | May 20, 2022, 04:47 PM |
| Mow Jonathan P | Chief Executive Officer | Nov 19, 2021 | Option Exercise | $2.01 | 5,623 | 11,302 | 172,473 | Nov 23, 2021, 06:55 PM |
| Arnold Susan Elizabeth | SVP, Technical Operations | Nov 19, 2021 | Option Exercise | $2.01 | 2,559 | 5,144 | 30,319 | Nov 23, 2021, 06:54 PM |
| Sharp John P | Chief Financial Officer | Nov 19, 2021 | Option Exercise | $2.01 | 2,017 | 4,054 | 59,741 | Nov 23, 2021, 06:53 PM |
| Hanson Kristopher | VP, Head of Legal | Nov 19, 2021 | Option Exercise | $2.01 | 1,545 | 3,105 | 3,632 | Nov 23, 2021, 06:51 PM |
| Burkhardt Glen | VP, Human Resources | Nov 19, 2021 | Option Exercise | $2.01 | 5,766 | 11,590 | 5,766 | Nov 23, 2021, 06:50 PM |
| Burkhardt Glen | VP, Human Resources | Nov 19, 2021 | Sale | $2.37 | 5,766 | 13,665 | 0 | Nov 23, 2021, 06:50 PM |
| Hutson Nancy J | Director | Nov 05, 2021 | Option Exercise | $2.31 | 26,360 | 60,909 | 26,360 | Nov 08, 2021, 06:26 PM |
| Hutson Nancy J | Director | Nov 08, 2021 | Option Exercise | $3.15 | 7,400 | 23,310 | 33,760 | Nov 08, 2021, 06:26 PM |
| Mow Jonathan P | Chief Executive Officer | Nov 03, 2021 | Option Exercise | $1.24 | 20,000 | 24,800 | 166,850 | Nov 03, 2021, 07:30 PM |
| Sharp John P | Chief Financial Officer | Nov 03, 2021 | Option Exercise | $1.68 | 7,500 | 12,600 | 57,724 | Nov 03, 2021, 07:30 PM |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | Jul 12, 2021 | Option Exercise | $1.74 | 4,519 | 7,863 | 27,760 | Sep 03, 2021, 04:43 PM |
| Sharp John P | Chief Financial Officer | Aug 03, 2021 | Option Exercise | $1.68 | 7,500 | 12,600 | 50,224 | Sep 03, 2021, 04:41 PM |
| Mow Jonathan P | Chief Executive Officer | Aug 27, 2021 | Option Exercise | $1.24 | 20,000 | 24,800 | 146,850 | Aug 30, 2021, 05:52 PM |
| Hutson Nancy J | Director | Aug 18, 2021 | Buy | $3.08 | 3,000 | 9,240 | 4,000 | Aug 19, 2021, 04:24 PM |
| Thorp Clay | Director | Aug 18, 2021 | Buy | $3.00 | 10,000 | 30,000 | 32,943 | Aug 18, 2021, 06:07 PM |
| Sharp John P | Chief Financial Officer | Aug 03, 2021 | Option Exercise | $1.68 | 7,500 | 12,600 | 50,224 | Aug 04, 2021, 06:58 PM |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | Jul 12, 2021 | Option Exercise | $1.74 | 4,519 | 7,863 | 27,760 | Jul 14, 2021, 07:06 PM |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | May 20, 2021 | Option Exercise | $2.80 | 5,257 | 14,720 | 23,241 | May 24, 2021, 06:09 PM |
| Hanson Kristopher | VP, Head of Legal | May 20, 2021 | Option Exercise | $2.80 | 1,088 | 3,046 | 2,087 | May 24, 2021, 06:09 PM |
| HARRIGAN EDMUND | Director | Dec 03, 2020 | Buy | $4.12 | 6,000 | 24,720 | 6,000 | Dec 04, 2020, 03:53 PM |
| Thorp Clay | Director | Nov 24, 2020 | Buy | $3.50 | 2,000 | 7,000 | 22,943 | Nov 24, 2020, 04:04 PM |
| Thorp Clay | Director | Nov 23, 2020 | Buy | $3.67 | 3,000 | 11,010 | 20,943 | Nov 24, 2020, 04:04 PM |
| Sharp John P | Chief Financial Officer | Nov 20, 2020 | Option Exercise | $3.00 | 1,305 | 3,915 | 41,305 | Nov 23, 2020, 06:43 PM |
| Hanson Kristopher | VP, Head of Legal | Nov 20, 2020 | Option Exercise | $3.00 | 999 | 2,997 | 999 | Nov 23, 2020, 06:42 PM |
| York Michael | VP, Corporate Development | Nov 20, 2020 | Option Exercise | $3.00 | 2,662 | 7,986 | 4,162 | Nov 23, 2020, 06:40 PM |
| Ballance David James | VP, Research and Sci. Affairs | Nov 20, 2020 | Option Exercise | $3.00 | 919 | 2,757 | 8,519 | Nov 23, 2020, 06:38 PM |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | Nov 20, 2020 | Option Exercise | $3.00 | 4,832 | 14,496 | 17,984 | Nov 23, 2020, 06:36 PM |
| Mow Jonathan P | Chief Executive Officer | Nov 20, 2020 | Option Exercise | $3.00 | 3,643 | 10,929 | 122,886 | Nov 23, 2020, 06:34 PM |
| Burkhardt Glen | VP, Human Resources | Nov 20, 2020 | Option Exercise | $3.00 | 3,497 | 10,491 | 3,497 | Nov 23, 2020, 06:27 PM |
| Burkhardt Glen | VP, Human Resources | Nov 23, 2020 | Sale | $3.45 | 3,497 | 12,065 | 0 | Nov 23, 2020, 06:27 PM |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | Oct 01, 2020 | Option Exercise | $1.15 | 5,423 | 6,236 | 13,152 | Oct 05, 2020, 09:08 PM |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | Feb 27, 2020 | Option Exercise | $1.15 | 5,423 | 6,236 | 7,729 | Oct 05, 2020, 09:08 PM |
| Mow Jonathan P | Chief Executive Officer | Aug 21, 2020 | Option Exercise | $1.24 | 10,000 | 12,400 | 119,243 | Aug 24, 2020, 07:04 PM |
| Sharp John P | Chief Financial Officer | Aug 14, 2020 | Option Exercise | $1.69 | 5,000 | 8,450 | 40,000 | Aug 17, 2020, 08:15 PM |
| Mow Jonathan P | Chief Executive Officer | Sep 06, 2019 | Option Exercise | $1.24 | 19,000 | 23,560 | 109,243 | Sep 10, 2019, 04:10 PM |
| Sharp John P | CFO and Secretary | Aug 21, 2019 | Option Exercise | $1.61 | 15,000 | 24,100 | 35,000 | Aug 22, 2019, 07:42 PM |
| Thorp Clay | Director | Jul 01, 2019 | Sale | $14.00 | 2,014 | 28,196 | 1,818,638 | Jul 03, 2019, 04:28 PM |
| Thorp Clay | Director | Jul 01, 2019 | Sale | $14.00 | 459 | 6,426 | 415,959 | Jul 03, 2019, 04:28 PM |
| Thorp Clay | Director | Jul 01, 2019 | Sale | $14.00 | 255 | 3,570 | 52,397 | Jul 03, 2019, 04:28 PM |
| Thorp Clay | Director | Jul 01, 2019 | Sale | $14.00 | 180 | 2,520 | 162,890 | Jul 03, 2019, 04:28 PM |
| Thorp Clay | Director | Jun 18, 2019 | Sale | $14.00 | 63 | 882 | 416,418 | Jun 20, 2019, 07:09 PM |
| Thorp Clay | Director | Jun 18, 2019 | Sale | $14.00 | 35 | 490 | 52,655 | Jun 20, 2019, 07:09 PM |
| Thorp Clay | Director | Jun 18, 2019 | Sale | $14.00 | 25 | 350 | 163,074 | Jun 20, 2019, 07:09 PM |
| Thorp Clay | Director | Jun 18, 2019 | Sale | $14.00 | 277 | 3,878 | 1,820,656 | Jun 20, 2019, 07:09 PM |
| Sharp John P | CFO and Secretary | May 22, 2019 | Option Exercise | $1.69 | 15,000 | 25,350 | 20,000 | May 24, 2019, 02:22 PM |
| Mow Jonathan P | Chief Executive Officer | May 17, 2019 | Option Exercise | $2.27 | 19,913 | 45,203 | 71,112 | May 21, 2019, 06:27 PM |
| Mow Jonathan P | Chief Executive Officer | May 20, 2019 | Option Exercise | $1.24 | 19,131 | 23,722 | 90,243 | May 21, 2019, 06:27 PM |
| Ballance David James | VP, Research and Sci. Affairs | Dec 13, 2018 | Buy | $3.94 | 1,000 | 3,940 | 7,600 | Dec 17, 2018, 04:24 PM |
| Hutson Nancy J | Director | Dec 17, 2018 | Buy | $4.46 | 1,000 | 4,460 | 1,000 | Dec 17, 2018, 04:19 PM |
| Mow Jonathan P | Chief Executive Officer | Dec 13, 2018 | Buy | $3.69 | 1,000 | 3,690 | 51,199 | Dec 17, 2018, 04:18 PM |
| Mow Jonathan P | Chief Executive Officer | Dec 10, 2018 | Buy | $3.85 | 800 | 3,080 | 50,199 | Dec 13, 2018, 05:04 PM |
| Mow Jonathan P | Chief Executive Officer | Dec 07, 2018 | Buy | $3.89 | 700 | 2,723 | 49,399 | Dec 13, 2018, 05:04 PM |
| York Michael | VP, Corporate Development | Dec 11, 2018 | Buy | $3.88 | 1,500 | 5,820 | 1,500 | Dec 11, 2018, 04:18 PM |
| Sharp John P | CFO and Secretary | Dec 07, 2018 | Buy | $3.84 | 5,000 | 19,200 | 5,000 | Dec 11, 2018, 04:16 PM |
| Mow Jonathan P | Chief Executive Officer | Dec 10, 2018 | Buy | $3.85 | 800 | 3,080 | 51,699 | Dec 11, 2018, 04:12 PM |
| Mow Jonathan P | Chief Executive Officer | Dec 07, 2018 | Buy | $3.88 | 2,200 | 8,536 | 50,899 | Dec 11, 2018, 04:12 PM |
| Thorp Clay | Director | Dec 04, 2018 | Buy | $3.13 | 4,000 | 12,520 | 15,799 | Dec 06, 2018, 09:15 AM |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Oct 22, 2018 | Buy | $5.00 | 1,800,000 | 9,000,000 | 6,641,634 | Oct 24, 2018, 05:01 PM |
| TUFTS LINDA | Director | Oct 22, 2018 | Buy | $5.00 | 6,041 | 30,205 | 281,096 | Oct 24, 2018, 04:20 PM |
| TUFTS LINDA | Director | Oct 22, 2018 | Buy | $5.00 | 1,277 | 6,385 | 59,429 | Oct 24, 2018, 04:20 PM |
| TUFTS LINDA | Director | Oct 22, 2018 | Buy | $5.00 | 12,682 | 63,410 | 590,168 | Oct 24, 2018, 04:20 PM |
| Thorp Clay | Director | Oct 22, 2018 | Buy | $5.00 | 12,487 | 62,435 | 163,099 | Oct 24, 2018, 04:19 PM |
| Thorp Clay | Director | Oct 22, 2018 | Buy | $5.00 | 137,513 | 687,565 | 1,820,933 | Oct 24, 2018, 04:19 PM |
| Thorp Clay | Director | Oct 22, 2018 | Buy | $5.00 | 150,000 | 750,000 | 416,481 | Oct 24, 2018, 04:19 PM |
| Hatteras Venture Advisors III, LLC | 10% Owner | Oct 22, 2018 | Buy | $5.00 | 150,000 | 750,000 | 416,481 | Oct 24, 2018, 04:18 PM |
| Hatteras Venture Advisors III, LLC | 10% Owner | Oct 22, 2018 | Buy | $5.00 | 12,487 | 62,435 | 163,099 | Oct 24, 2018, 04:18 PM |
| Hatteras Venture Advisors III, LLC | 10% Owner | Oct 22, 2018 | Buy | $5.00 | 137,513 | 687,565 | 1,820,933 | Oct 24, 2018, 04:18 PM |
| ASTRAZENECA PLC | 10% Owner | Oct 22, 2018 | Buy | $5.00 | 600,000 | 3,000,000 | 3,004,554 | Oct 24, 2018, 04:16 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | 10/25/2022 | 262,264 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | 10/25/2022 | 262,264 |
| Arnold Susan Elizabeth | SVP, Technical Operations | 05/20/2022 | 7,438 |
| Mow Jonathan P | Chief Executive Officer | 05/20/2022 | 7,438 |
| Burkhardt Glen | SVP of Human Resources | 05/20/2022 | 7,663 |
| Burkhardt Glen | SVP of Human Resources | 05/23/2022 | 8,886 |
| Hanson Kristopher | SVP and General Counsel | 05/20/2022 | 3,291 |
| Birchall Jonathan | Chief Commercial Officer | 05/20/2022 | 13,626 |
| Sharp John P | Chief Financial Officer | 05/20/2022 | 4,106 |
| Hutson Nancy J | Director | 08/18/2021 | 9,240 |
| Mow Jonathan P | Chief Executive Officer | 11/19/2021 | 11,302 |
| Arnold Susan Elizabeth | SVP, Technical Operations | 11/19/2021 | 5,144 |
| Sharp John P | Chief Financial Officer | 11/19/2021 | 4,054 |
| Hanson Kristopher | VP, Head of Legal | 11/19/2021 | 3,105 |
| Burkhardt Glen | VP, Human Resources | 11/19/2021 | 11,590 |
| Burkhardt Glen | VP, Human Resources | 11/19/2021 | 13,665 |
| Hutson Nancy J | Director | 11/05/2021 | 60,909 |
| Hutson Nancy J | Director | 11/08/2021 | 23,310 |
| Mow Jonathan P | Chief Executive Officer | 11/03/2021 | 24,800 |
| Sharp John P | Chief Financial Officer | 11/03/2021 | 12,600 |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | 07/12/2021 | 7,863 |
| Sharp John P | Chief Financial Officer | 08/03/2021 | 12,600 |
| Mow Jonathan P | Chief Executive Officer | 08/27/2021 | 24,800 |
| Hutson Nancy J | Director | 08/18/2021 | 9,240 |
| Thorp Clay | Director | 08/18/2021 | 30,000 |
| Sharp John P | Chief Financial Officer | 08/03/2021 | 12,600 |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | 07/12/2021 | 7,863 |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | 05/20/2021 | 14,720 |
| Hanson Kristopher | VP, Head of Legal | 05/20/2021 | 3,046 |
| HARRIGAN EDMUND | Director | 12/03/2020 | 24,720 |
| Thorp Clay | Director | 11/24/2020 | 7,000 |
| Thorp Clay | Director | 11/23/2020 | 11,010 |
| Sharp John P | Chief Financial Officer | 11/20/2020 | 3,915 |
| Hanson Kristopher | VP, Head of Legal | 11/20/2020 | 2,997 |
| York Michael | VP, Corporate Development | 11/20/2020 | 7,986 |
| Ballance David James | VP, Research and Sci. Affairs | 11/20/2020 | 2,757 |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | 11/20/2020 | 14,496 |
| Mow Jonathan P | Chief Executive Officer | 11/20/2020 | 10,929 |
| Burkhardt Glen | VP, Human Resources | 11/20/2020 | 10,491 |
| Burkhardt Glen | VP, Human Resources | 11/23/2020 | 12,065 |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | 10/01/2020 | 6,236 |
| Arnold Susan Elizabeth | VP, Preclinical and Chem | 02/27/2020 | 6,236 |
| Mow Jonathan P | Chief Executive Officer | 08/21/2020 | 12,400 |
| Sharp John P | Chief Financial Officer | 08/14/2020 | 8,450 |
| Mow Jonathan P | Chief Executive Officer | 09/06/2019 | 23,560 |
| Sharp John P | CFO and Secretary | 08/21/2019 | 24,100 |
| Thorp Clay | Director | 07/01/2019 | 28,196 |
| Thorp Clay | Director | 07/01/2019 | 6,426 |
| Thorp Clay | Director | 07/01/2019 | 3,570 |
| Thorp Clay | Director | 07/01/2019 | 2,520 |
| Thorp Clay | Director | 06/18/2019 | 882 |
| Thorp Clay | Director | 06/18/2019 | 490 |
| Thorp Clay | Director | 06/18/2019 | 350 |
| Thorp Clay | Director | 06/18/2019 | 3,878 |
| Sharp John P | CFO and Secretary | 05/22/2019 | 25,350 |
| Mow Jonathan P | Chief Executive Officer | 05/17/2019 | 45,203 |
| Mow Jonathan P | Chief Executive Officer | 05/20/2019 | 23,722 |
| Ballance David James | VP, Research and Sci. Affairs | 12/13/2018 | 3,940 |
| Hutson Nancy J | Director | 12/17/2018 | 4,460 |
| Mow Jonathan P | Chief Executive Officer | 12/13/2018 | 3,690 |
| Mow Jonathan P | Chief Executive Officer | 12/10/2018 | 3,080 |
| Mow Jonathan P | Chief Executive Officer | 12/07/2018 | 2,723 |
| York Michael | VP, Corporate Development | 12/11/2018 | 5,820 |
| Sharp John P | CFO and Secretary | 12/07/2018 | 19,200 |
| Mow Jonathan P | Chief Executive Officer | 12/10/2018 | 3,080 |
| Mow Jonathan P | Chief Executive Officer | 12/07/2018 | 8,536 |
| Thorp Clay | Director | 12/04/2018 | 12,520 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | 10/22/2018 | 9,000,000 |
| TUFTS LINDA | Director | 10/22/2018 | 30,205 |
| TUFTS LINDA | Director | 10/22/2018 | 6,385 |
| TUFTS LINDA | Director | 10/22/2018 | 63,410 |
| Thorp Clay | Director | 10/22/2018 | 62,435 |
| Thorp Clay | Director | 10/22/2018 | 687,565 |
| Thorp Clay | Director | 10/22/2018 | 750,000 |
| Hatteras Venture Advisors III, LLC | 10% Owner | 10/22/2018 | 750,000 |
| Hatteras Venture Advisors III, LLC | 10% Owner | 10/22/2018 | 62,435 |
| Hatteras Venture Advisors III, LLC | 10% Owner | 10/22/2018 | 687,565 |
| ASTRAZENECA PLC | 10% Owner | 10/22/2018 | 3,000,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR PHASEBIO PHARMACEUTICALS INC
LOADING...